Beatriz San Martín, Partner, IP and Technology, Protection and Enforcement
I am an intellectual property specialist with a focus on the life sciences sector and emerging/disruptive technologies. Prior to pursuing a legal career, I was a scientist with a degree and a Wellcome Trust PhD and postdoc from the University of Cambridge specialising in genetics, cellular and molecular biology.
I have significant experience litigating before the UK Courts and the Court of Justice of the European Union, having acted in a number of leading reported IP cases. I have worked on several patent cases on behalf of Eli Lilly & Company including a preliminary reference to the Court of Justice of the European Union concerning the interpretation of the SPC Regulation and a case before the Court of Appeal. I have also assisted on several medical device and medical instrumentation patent cases and in the largest ever confidential information case in England & Wales.
Though my practice centres on dispute resolution, it need not necessarily involve the courts. I counsel on international IP protection and enforcement strategies, IP infringement avoidance, infringement and validity opinions, licensing issues and provide corporate support on transactions with patent issues.
Chambers 2016 has ranked me as a leading IP individual who "impresses in sophisticated patent and confidential information cases. Sources describe her as "a very creative, thoughtful litigator" who "excels in managing complex, multi-jurisdictional cases." I have also been selected as a WIPR Leader for 2015 and, in November 2015, I was named one of BioBeat's 50 female 'Movers and Shakers' in BioBusiness.
I am member of the Cellular & Gene Therapy Advisory Committee at the BioIndustry Association and I am Fieldfisher's representative at the Intellectual Property Lawyers' Association (IPLA). I am also a member of the Chartered Institute of Patent Attorneys (CIPA), the International Association for the Protection of Intellectual Property (AIPPI), the American Intellectual Property Lawyers' Association (AIPLA) and the European Lawyers' Association (EPLAW).
I regularly contribute articles to professional publications and am on the editorial advisory board of Cell & Gene Therapy Insights. For the past nine years I have coordinated a series of IP lectures for the University of Cambridge Masters in Bioscience Enterprise and I lecture on the course. My speaking engagements in the past 12 months have included several presentations on the draft Trade Secrets Directive, a presentation on SPCs and the unitary patent package, a lecture on patentability of biotech/pharma inventions and a workshop on the legal position on genome editing.
I am bilingual in Spanish and English, with a good understanding of French.